BioHealth News
Sirnaomics Announces Interim Results for Successful Completion of the Second Cohort of Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Therapeutics
HONG KONG and GERMANTOWN, Md. and SUZHOU, China, July 8, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", together with its subsidiaries, the "Group" or "Sirnaomics"; stock code: 2257), a leading biopharmaceutical…
Read More
Maryland Awards $500K to Early Charm Ventures for Biomanufacturing Incubator at Harford County Facility
BEL AIR, Md., (July 1, 2024) – Maryland Department of Commerce has awarded $500K to Baltimore-based Early Charm to develop a biomanufacturing incubator at a…
Read More
Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products
GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received more than $250 million in contract modifications from the Administration for Strategic…
Read More
EDA: Biden-Harris Administration Announces Next Funding Round of $504 Million for 12 Tech Hubs Across America
WASHINGTON, DC — The Biden-Harris Administration, through the U.S. Department of Commerce’s Economic Development Administration (EDA), announced another funding round of approximately $504 million in implementation…
Read More
Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing
GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for…
Read More
Cartesian Therapeutics Announces Positive Topline Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis
GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (“Cartesian” or the “Company”), a clinical-stage biotechnology company pioneering mRNA cell…
Read More
TJP: 2023 Crab Trap Finalist EyeControl creates revolutionary medical technology
EyeControl improves clinical outcomes, prevent cognitive decline, and enhance the patient and family experience.“We are honoured to be able to support every patient –…
Read More
From Tunisia to Maryland: FluoInk’s Journey at the SelectUSA Investment Summit
Professor Ramzi Maalej, CTO and Founder of FluoInk, recently traveled from Tunisia to Maryland to attend the SelectUSA Investment Summit. FluoInk is currently working…
Read More
Shaping the Future of Health Computing in the BioHealth Capital Region: Insights from Dr. Bradley Maron on BioTalk
Join us for an episode of BioTalk with Rich Bendis featuring Dr. Bradley Maron, Senior Associate Dean for Precision Medicine and Executive Co-Director…
Read More
BioHealth Capital Region Week 2024 Registration Now Open
Join us this September for the BioHealth Capital Region Week 2024, a gathering that epitomizes the spirit of innovation in the biopharma industry. Hosted…
Read More
Gain Therapeutics Appoints Gene Mack as Interim CEO
BETHESDA, Md., June 27, 2024 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX), a clinical-stage biotechnology company leading the discovery and development of the next generation…
Read More
ARPA-H announces small business funding opportunity
Agency seeks proposals for innovative research and development from small businesses The Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S.…
Read More
CraniUS™ Awarded Competitive $1 Million Grant from the State of Maryland’s Build Our Future Innovation Infrastructure Program
BALTIMORE--(BUSINESS WIRE)--CraniUS™, an R&D company focused on groundbreaking diagnostics and treatments for patients with chronic brain disease, has been awarded a competitive $1 million…
Read More
TEDCO Announces Second Year of Maryland Makerspace Initiative Program Awardees
18 projects will receive funding to support their growth and development COLUMBIA, Md., (June 27, 2024) — TEDCO, Maryland’s economic engine for technology companies,…
Read More
Fierce Healthcare: AWS doles out part of $10M grant to major children’s hospitals to advance pediatric cancer treatment
WASHINGTON, D.C. — Amazon Web Services committed $10 million to fund pediatric rare disease research, including cancer, on Wednesday at its annual summit in…
Read More